242 related articles for article (PubMed ID: 25590303)
1. Mechanisms and implications of dual-acting methotrexate in folate-targeted nanotherapeutic delivery.
Wong PT; Choi SK
Int J Mol Sci; 2015 Jan; 16(1):1772-90. PubMed ID: 25590303
[TBL] [Abstract][Full Text] [Related]
2. Avidity modulation of folate-targeted multivalent dendrimers for evaluating biophysical models of cancer targeting nanoparticles.
Silpe JE; Sumit M; Thomas TP; Huang B; Kotlyar A; van Dongen MA; Banaszak Holl MM; Orr BG; Choi SK
ACS Chem Biol; 2013 Sep; 8(9):2063-71. PubMed ID: 23855478
[TBL] [Abstract][Full Text] [Related]
3. Integration of phospholipid-hyaluronic acid-methotrexate nanocarrier assembly and amphiphilic drug-drug conjugate for synergistic targeted delivery and combinational tumor therapy.
Li Y; Zhang H; Chen Y; Ma J; Lin J; Zhang Y; Fan Z; Su G; Xie L; Zhu X; Hou Z
Biomater Sci; 2018 Jun; 6(7):1818-1833. PubMed ID: 29785434
[TBL] [Abstract][Full Text] [Related]
4. Polyvalent dendrimer-methotrexate as a folate receptor-targeted cancer therapeutic.
Thomas TP; Huang B; Choi SK; Silpe JE; Kotlyar A; Desai AM; Zong H; Gam J; Joice M; Baker JR
Mol Pharm; 2012 Sep; 9(9):2669-2676. PubMed ID: 22827500
[TBL] [Abstract][Full Text] [Related]
5. Design and in vitro validation of multivalent dendrimer methotrexates as a folate-targeting anticancer therapeutic.
Thomas TP; Joice M; Sumit M; Silpe JE; Kotlyar A; Bharathi S; Kukowska-Latallo J; Baker JR; Choi SK
Curr Pharm Des; 2013; 19(37):6594-605. PubMed ID: 23621534
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and biological functionality of a dendrimer-based modular drug delivery platform.
Mullen DG; McNerny DQ; Desai A; Cheng XM; Dimaggio SC; Kotlyar A; Zhong Y; Qin S; Kelly CV; Thomas TP; Majoros I; Orr BG; Baker JR; Banaszak Holl MM
Bioconjug Chem; 2011 Apr; 22(4):679-89. PubMed ID: 21425790
[TBL] [Abstract][Full Text] [Related]
7. Dendrimer-based multivalent methotrexates as dual acting nanoconjugates for cancer cell targeting.
Li MH; Choi SK; Thomas TP; Desai A; Lee KH; Kotlyar A; Banaszak Holl MM; Baker JR
Eur J Med Chem; 2012 Jan; 47(1):560-72. PubMed ID: 22142685
[TBL] [Abstract][Full Text] [Related]
8. Conjugation Dependent Interaction of Folic Acid with Folate Binding Protein.
Merzel RL; Frey C; Chen J; Garn R; van Dongen M; Dougherty CA; Kandaluru AK; Low PS; Marsh ENG; Banaszak Holl MM
Bioconjug Chem; 2017 Sep; 28(9):2350-2360. PubMed ID: 28731321
[TBL] [Abstract][Full Text] [Related]
9. Folate Receptor-Targeted Dendrimer-Methotrexate Conjugate for Inflammatory Arthritis.
Qi R; Majoros I; Misra AC; Koch AE; Campbell P; Marotte H; Bergin IL; Cao Z; Goonewardena S; Morry J; Zhang S; Beer M; Makidon P; Kotlyar A; Thomas TP; Baker JR
J Biomed Nanotechnol; 2015 Aug; 11(8):1431-41. PubMed ID: 26295143
[TBL] [Abstract][Full Text] [Related]
10. Preclinical antitumor efficacy evaluation of dendrimer-based methotrexate conjugates.
Myc A; Douce TB; Ahuja N; Kotlyar A; Kukowska-Latallo J; Thomas TP; Baker JR
Anticancer Drugs; 2008 Feb; 19(2):143-9. PubMed ID: 18176110
[TBL] [Abstract][Full Text] [Related]
11. Folate receptor targeted 17-allylamino-17-demethoxygeldanamycin (17-AAG) loaded polymeric nanoparticles for breast cancer.
Saxena V; Naguib Y; Hussain MD
Colloids Surf B Biointerfaces; 2012 Jun; 94():274-80. PubMed ID: 22377218
[TBL] [Abstract][Full Text] [Related]
12. Dual antitumoral potency of EG5 siRNA nanoplexes armed with cytotoxic bifunctional glutamyl-methotrexate targeting ligand.
Lee DJ; Kessel E; Edinger D; He D; Klein PM; Voith von Voithenberg L; Lamb DC; Lächelt U; Lehto T; Wagner E
Biomaterials; 2016 Jan; 77():98-110. PubMed ID: 26584350
[TBL] [Abstract][Full Text] [Related]
13. Targeted delivery of 5-fluorouracil to HT-29 cells using high efficient folic acid-conjugated nanoparticles.
Wang Y; Li P; Chen L; Gao W; Zeng F; Kong LX
Drug Deliv; 2015 Feb; 22(2):191-8. PubMed ID: 24437926
[TBL] [Abstract][Full Text] [Related]
14. Folate-mediated chemotherapy and diagnostics: An updated review and outlook.
Xu L; Bai Q; Zhang X; Yang H
J Control Release; 2017 Apr; 252():73-82. PubMed ID: 28235591
[TBL] [Abstract][Full Text] [Related]
15. Carrier-free, functionalized drug nanoparticles for targeted drug delivery.
Li W; Yang Y; Wang C; Liu Z; Zhang X; An F; Diao X; Hao X; Zhang X
Chem Commun (Camb); 2012 Aug; 48(65):8120-2. PubMed ID: 22766919
[TBL] [Abstract][Full Text] [Related]
16. Folate Receptor-Targeted and GSH-Responsive Carboxymethyl Chitosan Nanoparticles Containing Covalently Entrapped 6-Mercaptopurine for Enhanced Intracellular Drug Delivery in Leukemia.
Wei X; Liao J; Davoudi Z; Zheng H; Chen J; Li D; Xiong X; Yin Y; Yu X; Xiong J; Wang Q
Mar Drugs; 2018 Nov; 16(11):. PubMed ID: 30413077
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and cellular uptake of folic acid-conjugated cellulose nanocrystals for cancer targeting.
Dong S; Cho HJ; Lee YW; Roman M
Biomacromolecules; 2014 May; 15(5):1560-7. PubMed ID: 24716601
[TBL] [Abstract][Full Text] [Related]
18. In vitro control release, cytotoxicity assessment and cellular uptake of methotrexate loaded liquid-crystalline folate nanocarrier.
Misra R; Upadhyay M; Perumal V; Mohanty S
Biomed Pharmacother; 2015 Feb; 69():102-10. PubMed ID: 25661345
[TBL] [Abstract][Full Text] [Related]
19. Targeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex.
Patri AK; Kukowska-Latallo JF; Baker JR
Adv Drug Deliv Rev; 2005 Dec; 57(15):2203-14. PubMed ID: 16290254
[TBL] [Abstract][Full Text] [Related]
20. Folate-conjugated β-cyclodextrin from click chemistry strategy and for tumor-targeted drug delivery.
Zhang H; Cai Z; Sun Y; Yu F; Chen Y; Sun B
J Biomed Mater Res A; 2012 Sep; 100(9):2441-9. PubMed ID: 22566147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
